Journal article
A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion
Abstract
The risks and benefits of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CS/HIPEC) continue to be debated by the oncology community. A retrospective analysis of contemporary data (2003-2011) was performed to provide objective information regarding surgical morbidity, mortality, and survival for patients undergoing CS/HIPEC at a comprehensive cancer center. While procedure-associated morbidity was comparable to …
Authors
Haslinger M; Francescutti V; Attwood K; McCart JA; Fakih M; Kane JM; Skitzki JJ
Journal
Cancer Medicine, Vol. 2, No. 3, pp. 334–342
Publisher
Wiley
Publication Date
June 2013
DOI
10.1002/cam4.80
ISSN
2045-7634